Clinical Data Interchange Standards in Clinical Trials on Alzheimer’s Disease

OBJECTIVE: The Clinical Data Interchange Standards Consortium (CDISC) proposed outcome measures for clinical trials on Alzheimer’s disease (AD) in the Therapeutic Area User Guide for AD (TAUG-AD). To investigate how well the clinical trials on AD registered in the ClinicalTrials.gov complied with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Na, Riyoung, Bae, Jong Bin, Jung, Sue Hyun, Kim, Ki Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633174/
https://www.ncbi.nlm.nih.gov/pubmed/36327961
http://dx.doi.org/10.30773/pi.2022.0149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633174/
https://www.ncbi.nlm.nih.gov/pubmed/36327961
http://dx.doi.org/10.30773/pi.2022.0149

Ejemplares similares